Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer International Publishing

9783319178066, 9783319178073

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Mechanisms and Modulation of Tumor Microenvironment-Induced Immune Resistance

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy ◽

10.1007/978-3-319-17807-3_7 ◽

2015 ◽

pp. 143-158

Author(s):

Tuna Mutis ◽

Niels W. C. J. van de Donk ◽

Richard W. J. Groen

Keyword(s):

Tumor Microenvironment ◽

Immune Resistance

Download Full-text

ERRATUM TO: Integrins: Friends or Foes of Antitumor Cytotoxic T Lymphocyte Response

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy ◽

10.1007/978-3-319-17807-3_15 ◽

2015 ◽

pp. E1-E1

Author(s):

Marie Boutet ◽

Stephanie Cognac ◽

Fathia Mami-Chouaib

Keyword(s):

T Lymphocyte ◽

Cytotoxic T Lymphocyte ◽

Lymphocyte Response ◽

Cytotoxic T Lymphocyte Response

Download Full-text

Epithelial Mesenchymal Transition Influence on CTL Activity

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy ◽

10.1007/978-3-319-17807-3_12 ◽

2015 ◽

pp. 267-284

Author(s):

Wilfried Engl ◽

Virgile Viasnoff ◽

Jean Paul Thiery

Keyword(s):

Epithelial Mesenchymal Transition ◽

Mesenchymal Transition ◽

Ctl Activity

Download Full-text

Role of the Non-classical HLA Class I Antigens for Immune Escape

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy ◽

10.1007/978-3-319-17807-3_3 ◽

2015 ◽

pp. 59-72

Author(s):

Barbara Seliger ◽

Simon Jasinski-Bergner

Keyword(s):

Immune Escape ◽

Hla Class I ◽

Class I ◽

Hla Class I Antigens

Download Full-text

Cancer Induced Immunosuppression and Its Modulation by Signal Inhibitors

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy ◽

10.1007/978-3-319-17807-3_13 ◽

2015 ◽

pp. 287-301

Author(s):

Yutaka Kawakami ◽

Li Qian ◽

Naoshi Kawamura ◽

Junichiro Miyazaki ◽

Kinya Tsubota ◽

...

Download Full-text

Pancreatic Cancer Resistance to TRAIL Therapy: Regulators of the Death Inducing Signaling Complex

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy ◽

10.1007/978-3-319-17807-3_11 ◽

2015 ◽

pp. 235-265

Author(s):

Yabing Chen ◽

Kaiyu Yuan ◽

Jay McDonald

Keyword(s):

Pancreatic Cancer ◽

Cancer Resistance ◽

Signaling Complex

Download Full-text

Overcoming Cancer Cell Resistance to Death Receptor Targeted Therapies

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy ◽

10.1007/978-3-319-17807-3_10 ◽

2015 ◽

pp. 209-233

Author(s):

Julianne D. Twomey ◽

William Hallett ◽

Baolin Zhang

Keyword(s):

Cancer Cell ◽

Targeted Therapies ◽

Death Receptor ◽

Cell Resistance

Download Full-text

Evasion of Cytotoxic Lymphocyte and Pulmonary Macrophage-Mediated Immune Responses in Lung Cancer

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy ◽

10.1007/978-3-319-17807-3_8 ◽

2015 ◽

pp. 159-174

Author(s):

Sandra Hodge ◽

Greg Hodge

Keyword(s):

Lung Cancer ◽

Immune Responses ◽

Cytotoxic Lymphocyte ◽

Pulmonary Macrophage

Download Full-text

Integrins: Friends or Foes of Antitumor Cytotoxic T Lymphocyte Response

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy ◽

10.1007/978-3-319-17807-3_4 ◽

2015 ◽

pp. 73-89

Author(s):

Marie Boutet ◽

Stephanie Cognac ◽

Fathia Mami-Chouaib

Keyword(s):

T Lymphocyte ◽

Cytotoxic T Lymphocyte ◽

Lymphocyte Response ◽

Cytotoxic T Lymphocyte Response

Download Full-text

Role of Co-inhibitory Molecules in Tumor Escape from CTL Attack

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy ◽

10.1007/978-3-319-17807-3_2 ◽

2015 ◽

pp. 31-58

Author(s):

Wieger J. Norde ◽

Willemijn Hobo ◽

Harry Dolstra

Keyword(s):

Tumor Escape ◽

Inhibitory Molecules

Download Full-text

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated ImmunotherapyLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer International Publishing

Mechanisms and Modulation of Tumor Microenvironment-Induced Immune Resistance

ERRATUM TO: Integrins: Friends or Foes of Antitumor Cytotoxic T Lymphocyte Response

Epithelial Mesenchymal Transition Influence on CTL Activity

Role of the Non-classical HLA Class I Antigens for Immune Escape

Cancer Induced Immunosuppression and Its Modulation by Signal Inhibitors

Pancreatic Cancer Resistance to TRAIL Therapy: Regulators of the Death Inducing Signaling Complex

Overcoming Cancer Cell Resistance to Death Receptor Targeted Therapies

Evasion of Cytotoxic Lymphocyte and Pulmonary Macrophage-Mediated Immune Responses in Lung Cancer

Integrins: Friends or Foes of Antitumor Cytotoxic T Lymphocyte Response

Role of Co-inhibitory Molecules in Tumor Escape from CTL Attack

Resistance to Targeted Anti-Cancer Therapeutics - Resistance of Cancer Cells to CTL-Mediated Immunotherapy
Latest Publications